title: Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release.
abstract: Glucagon-like peptide-1(7-36NH2) is a potent stimulator of insulin secretion, as well as of somatostatin-14 (SS-14) release from the pancreatic and gastric D-cells. To investigate the possible effects of this peptide on release of intestinal somatostatin (SS-28 and SS-14, rat intestinal cultures were treated with 10(-12)-10(-6) M GLP-1(7-36NH2), as well as with the structurally related peptides, GLP-1(1-36NH2) and GLP-2. Both forms of GLP-1 stimulated does-dependent increases in intestinal somatostatin; secretion reached 643 +/- 126% of controls (p < 0.001) after treatment with 10(-6) M GLP-1(7-36NH2), and 398 +/-76% of controls (p < 0.001) after 10(-6) M GLP-1(1-36NH2). Thus, GLP-1(7-36NH2) was more effective than GLP-1(1-36NH2) in stimulating secretion of intestinal somatostatin-like immunoreactivity (SLI) (p < 0.05). GLP-2 did not affect intestinal somatostatin release. Gel permeation analysis demonstrated that 10(-6) M GLP-1(7-36NH2) stimulated SS-28 by 2.9 +/- 0.4-fold and SS-14 by 9.1 +/- 3.7-fold, whereas GLP-1(1-36NH2) exerted equivalent effects (2.8 +/- 0.9-fold) on both forms of somatostatin. These findings define a novel biological role for GLP-1(7-36NH2) in the regulation of intestinal somatostatin secretion, and demonstrate that GLP-1(1-36NH2) exerts unique biological activities in this system.
authors.affiliation: Departments of Physiology and Medicine, University of Toronto, Canada. p.brubaker@utoronto.ca
authors.forename: P L
authors.initials: PL
authors.lastname: Brubaker
authors.forename: S
authors.initials: S
authors.lastname: Efendic
authors.forename: G R
authors.initials: GR
authors.lastname: Greenberg
mesh_terms: D000818:Animals; D003994:Bucladesine / Q000378:metabolism; D002478:Cells, Cultured; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D052216:Glucagon-Like Peptide 1; D053767:Glucagon-Like Peptide 2; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D010446:Peptide Fragments / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D013004:Somatostatin / Q000378:metabolism* / Q000494:pharmacology; D053561:Somatostatin-28; D013268:Stimulation, Chemical
chemical_list: D005768:Gastrointestinal Hormones; D053767:Glucagon-Like Peptide 2; D010446:Peptide Fragments; D010455:Peptides; D013004:Somatostatin; D003994:Bucladesine; D053561:Somatostatin-28; D052216:Glucagon-Like Peptide 1